» Articles » PMID: 10069337

Mena is Required for Neurulation and Commissure Formation

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 1999 Mar 9
PMID 10069337
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian enabled (Mena) is a member of a protein family thought to link signal transduction pathways to localized remodeling of the actin cytoskeleton. Mena binds directly to Profilin, an actin-binding protein that modulates actin polymerization. In primary neurons, Mena is concentrated at the tips of growth cone filopodia. Mena-deficient mice are viable; however, axons projecting from interhemispheric cortico-cortical neurons are misrouted in early neonates, and failed decussation of the corpus callosum as well as defects in the hippocampal commissure and the pontocerebellar pathway are evident in the adult. Mena-deficient mice that are heterozygous for a Profilin I deletion die in utero and display defects in neurulation, demonstrating an important functional role for Mena in regulation of the actin cytoskeleton.

Citing Articles

Elaboration of the Homer1 recognition landscape reveals incomplete divergence of paralogous EVH1 domains.

Singer A, Ramos A, Keating A Protein Sci. 2024; 33(8):e5094.

PMID: 38989636 PMC: 11237882. DOI: 10.1002/pro.5094.


Elaboration of the Homer1 Recognition Landscape Reveals Incomplete Divergence of Paralogous EVH1 Domains.

Singer A, Ramos A, Keating A bioRxiv. 2024; .

PMID: 38645240 PMC: 11030225. DOI: 10.1101/2024.01.23.576863.


Kinetic trapping organizes actin filaments within liquid-like protein droplets.

Chandrasekaran A, Graham K, Stachowiak J, Rangamani P Nat Commun. 2024; 15(1):3139.

PMID: 38605007 PMC: 11009352. DOI: 10.1038/s41467-024-46726-6.


Brain plasticity following corpus callosum agenesis or loss: a review of the Probst bundles.

Lynton Z, Suarez R, Fenlon L Front Neuroanat. 2023; 17:1296779.

PMID: 38020213 PMC: 10657877. DOI: 10.3389/fnana.2023.1296779.


The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors.

Gui J, Zhou H, Wan H, Yang D, Liu Q, Zhu L Curr Cancer Drug Targets. 2023; 24(5):477-489.

PMID: 37962042 PMC: 11092557. DOI: 10.2174/0115680096262439231023110106.